Effects of 5-HT(1A) receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

European Journal of Pharmacology

Volumn 304, Issue 1-3, 1996, Pages 15-21

  Assié, Marie Bernadette ^a   Koek, Wouter ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

(S) WAY100135; 5 HT (5 hydroxytryptamine, serotonin) level, extracellular; 5 HT(1A) receptor antagonist; microdialysis; WAY100635

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PARTIAL AGONIST; PHENTOLAMINE; PRAZOSIN; RADIOLIGAND; SEROTONIN; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SEROTONIN BRAIN LEVEL; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; CHEMISTRY; DRUG EFFECT; DRUG INTERACTION; IN VITRO STUDY; METABOLISM; PROTEIN BINDING; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG INTERACTIONS; HIPPOCAMPUS; MALE; PIPERAZINES; PRAZOSIN; PROTEIN BINDING; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0030598572     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00086-6     Document Type: Article

References (30)

1. Assié, M.-B. and W. Koek, 1994, Effects of (S)WAY 100135 on 5-HT levels in the ventral hippocampus of anaesthetized rat as measured by in vivo microdialysis, in: Monitoring Molecules in Neuroscience: Proceedings of the 6th Conference on in vivo Methods, eds. A. Louilot, T. Durkin, U. Spampinato and M. Cador (Publi Typ, Gradignan) p. 193.
2. 1A antagonist, WAY 100135, Soc. Neurosci. Abstr. 21, 727.18.
3. 1B, Neuropharmacology 35, 213.
4. Baraban, J.M. and G.K. Aghajanian, 1980, Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists, Neuropharmacology 19, 355.
5. 1A agonist gepirone: electrophysiological studies in the rat brain, Synapse 1, 470.
6. 1A agonists in anxiety and depression, J. Psychopharmacol. 7, 283.
7. Escandon, N.A., D.C. Zimmermann and R.B. McCall, 1994, Characterization of the serotonin1A receptor antagonist activity of WAY100135 and spiperone, J. Pharmacol. Exp. Ther. 268, 441.
8. 1A receptors, Eur. J. Pharmacol. 237, 283.
9. Fornal, CA., C.W. Metzler, S.C. Veasey, A.C. McCreary, C.T. Dourish and B.L. Jacobs, 1994, Single-unit recordings from freely moving animals provide evidence that WAY-100635, but not (S)-WAY-100135, blocks the action of endogenous serotonin at the 5-HT autoreceptor, Br. J. Pharmacol. 112, 92P.
10. 1A receptor antagonist, WAY100635, Eur. J. Pharmacol. 281, 81.
11. 1A receptor antagonist WAY-100635 on hippocampal 5-HT release in vivo, Br. J. Pharmacol. 112, 299P.
12. 1A receptors: behavioural and in vivo brain microdialysis studies. Life Sci. 46, 955.
13. Hjorth, S. and T. Sharp, 1993, In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol, J. Pharmacol. Exp. Ther. 265, 707.
14. 1-adrenoceptors in the inhibition of 5-HT release. I. BMY7378 and prazosin, Neuropharmacology 34, 615.
15. Hornung, R., P. Presek and H. Glossmann, 1979, Alpha adrenoceptors in rat brain: direct identification with prazosin, Naunyn Schmied. Arch. Pharmacol. 308, 223.
16. Kreiss, D.S., S. Wieland and I. Lucki, 1993, The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release, Neuroscience 52, 295.
17. 1A receptor ligands (+)-WAY100135 and SDZ 216-525, Eur. J. Pharmacol. 249, 25.
18. 1A receptors in the dorsal raphe nucleus, Eur. J. Pharmacol. 149, 9.
19. Meiler, E., M. Goldstein and K. Bohmaker, 1990, Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists, Mol. Pharmacol. 37, 231.
20. 1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus, Neuropharmacology 33, 61.
21. 1A antagonist WAY-100635 on 5-HT neuronal firing in the guinea-pig dorsal raphé nucleus, Br. J. Pharmacol. 112, 93P.
22. Paxinos, G. and C. Watson, 1986, The rat brain in stereotaxic coordinates (Academic Press, New York).
23. 1-Adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: A microdialysis study, Eur. J. Pharmacol. 261, 59.
24. 1A receptor antagonist WAY100135: An in vivo microdialysis study, Eur. J. Pharmacol. 239, 195.
25. Sharp, T., S.R. Bramwell, D. Clark and D.G. Grahame-Smith, 1989a, In vivo measurement of extracellular 5-hydroxytryptamine in hippocampus of the anaesthetized rat using microdialysis: changes in relation to 5-hydroxytryptaminergic neuronal activity, J. Neurochem. 53, 234.
26. Sharp, T., S.R. Bramwell, S. Hjorth and D.G. Grahame Smith, 1989b, Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis, Br. J. Pharmacol. 98, 989.
27. 1A antagonist, BMY 7378, Eur. J. Pharmacol. 176, 331.
28. Sleight, A.J. and S.J. Peroutka, 1991, Identification of 5-hydroxytryptamine1A receptor agents using a composite pharmacophore analysis and chemical database screening, Naunyn-Schmied. Arch. Pharmacol. 343, 109.
29. Sleight, A.J., C.A. Marsden, K.F. Martin and M.G. Palfreyman, 1988, Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan, Br. J. Pharmacol. 93, 303.
30. 1B agonists, Synapse 1, 3.